moderate ischemic mitral regurge
Not Applicable
- Conditions
- Circulatory Systemmitral valve diseaseCardiology
- Registration Number
- PACTR201710002640828
- Lead Sponsor
- menoufia university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients with coronary artery disease indicated for CABG
concomitant moderate ischemic mitral regurge.
Exclusion Criteria
emergency
ejection fraction less than 30
concomitant aortic surgery
concomitant carotid surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying ischemic mitral regurgitation in patients undergoing revascularization?
How does mitral valve repair combined with revascularization compare to revascularization alone in managing moderate ischemic mitral regurgitation?
Which biomarkers are associated with favorable outcomes in patients with moderate ischemic mitral regurgitation undergoing surgical intervention?
What are the potential adverse events of mitral valve repair in conjunction with coronary artery bypass grafting for ischemic mitral regurgitation?
Are there any novel drug therapies or combination approaches being explored for ischemic mitral regurgitation alongside surgical revascularization?